Original Research
Published on 05 Jun 2025
Reduced hemolytic complement activity in the classical pathway (CH50) is a risk factor for poor clinical outcomes of patients with infections: a retrospective analysis of health insurance claims in Japan
in Inflammation
- 2,973 views





